Ana M. Rivas-Grajales, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Ana Maria Rivas-Grajales is a Neuropsychiatrist and Assistant Professor in the Department of Psychiatry at Boston University Chobanian & Avedisian School of Medicine. Dr. Rivas-Grajales completed residency training in psychiatry at Baylor College of Medicine, and a clinical fellowship in Behavioral Neurology and Neuropsychiatry at Massachusetts General Hospital. She currently serves as the Director of the Transcranial Magnetic Stimulation Clinic at Boston Medical Center, where she provides care to patients with major depressive disorder. Her clinical expertise include neuropsychiatric complications of movement disorders, dementia, epilepsy and functional neurological disorder. Her research focuses on understanding of the mechanism of action of neuromodulation therapies for treatment-resistant depression, and identifying clinical and imaging biomarkers of rapid-acting antidepressants.

Publications

  • Published 1/10/2025

    Rivas-Grajales AM, Han SC, Wang R, Greenstein P, Shih LC. L266V MAPT Gene Mutation Associated With Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal Syndrome. J Neuropsychiatry Clin Neurosci. 2025 Jan 10; appineuropsych20240128. PMID: 39789940.

    Read at: PubMed

  • Published 12/19/2023

    Tanev KS, Camprodon JA, Caplan DN, Dickerson BC, Chemali Z, Eldaief MC, Kim DD, Josephy-Hernandez SE, Kritzer MD, Moo LR, Newhouse A, Perez DL, Ramirez Gomez LA, Razafsha M, Rivas-Grajales AM, Scharf JM, Schmahmann JD, Sherman JC. Telemedicine-Based Cognitive Examinations During COVID-19 and Beyond: Perspective of the Massachusetts General Hospital Behavioral Neurology & Neuropsychiatry Group. J Neuropsychiatry Clin Neurosci. 2024; 36(2):87-100. PMID: 38111331.

    Read at: PubMed

  • Published 5/1/2023

    Rivas-Grajales AM, Barbour T, Camprodon JA, Kritzer MD. The Impact of Sex Hormones on Transcranial Magnetic Stimulation Measures of Cortical Excitability: A Systematic Review and Considerations for Clinical Practice. Harv Rev Psychiatry. 2023 May-Jun 01; 31(3):114-123. PMID: 37171472.

    Read at: PubMed

  • Published 1/1/2023

    Carreon RL, Rivas-Grajales AM, Murphy N, Mathew SJ, Jha MK. Biomarkers in Psychiatric Drug Development: From Precision Medicine to Novel Therapeutics. Adv Neurobiol. 2023; 30:287-297. PMID: 36928855.

    Read at: PubMed

  • Published 1/1/2022

    Molton IR, Keatley E, Jaywant A, Josephy-Hernandez S, Rivas-Grajales AM, Perez DL, Mukherjee D. Ethical issues in the treatment of functional neurological disorder. PM R. 2022 01; 14(1):112-119. PMID: 34958180.

    Read at: PubMed

Education

  • Universidad Del Valle, MD
  • University College London (UCL), MSc